LXR Agonism Depletes MDSCs to Promote Antitumor Immunity
- PMID: 29352050
- DOI: 10.1158/2159-8290.CD-RW2018-010
LXR Agonism Depletes MDSCs to Promote Antitumor Immunity
Abstract
LXR activation reduces immunosuppressive MDSCs to activate antitumor cytotoxic T cells.
©2018 American Association for Cancer Research.
Comment on
-
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.Cell. 2018 Feb 8;172(4):825-840.e18. doi: 10.1016/j.cell.2017.12.026. Epub 2018 Jan 11. Cell. 2018. PMID: 29336888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources